A Pharmacoeconomic Analysis to Determine the Relative Cost-effectiveness of Timolol 0.5%, Brinzolamide 1% and Brimonidine 0.2% Eye Drops in Treatment of Primary Open Angle Glaucoma/Ocular Hypertension
Article
| IMSEAR
| ID: sea-183634
النص الكامل:
1
الفهرس:
IMSEAR
نوع الدراسة:
Clinical_trials
/
Health_economic_evaluation
/
Observational_studies
السنة:
2019
نوع:
Article